In 2024, we joined French Tech, strengthening ties with founders, mentors, and investors nationwide. The community’s energy and visibility support our goal to make clinician-guided, app-simple neuro-rehab accessible across Europe.
WILCO Approval — Accelerating EU Go-to-Market
Following our recent pitch, WILCO approved NerveAide. This milestone helps accelerate clinical validation, CE-MDR activities, and EU go-to-market while we raise our Seed round. Thank you to the mentors and partners supporting our mission to restore movement at scale.
Selected at “Les Afters du 30” — See you at Techinnov 2026
Thank you to Communauté Paris-Saclay and CCI Essonne for selecting NerveAide among 8 startups at Les Afters du 30. This support gives us access to Techinnov 2026 (24 March, Paris) to showcase how our connected FES devices help patients and seniors regain movement and confidence.
NerveAide at Slush 2025 — Investor & Partner Meetings
We joined Slush 2025 in Helsinki (Nov 19–20) to meet health investors, distributors, and clinical partners. With 5,400+ devices shipped, we’re opening our Seed round to scale connected neuro-rehab across Europe. If we missed you at Slush, let’s connect to discuss CE-MDR, clinical adoption, and EU rollout.
One Year at École Polytechnique’s X-Novation Center
Last year, NerveAide settled at École Polytechnique’s X-Novation Center. One year on, we’re celebrating momentum powered by the Paris-Saclay ecosystem—clinical links, investor dialogues, and a supportive community pushing connected neuro-rehab forward.
Proud Member of the French Tech Community
